Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 15 | 0 | 0 | 15 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
acid sphingomyelinase | 5 | 0 | 0 | 5 |
thioredoxin reductase | 62 | 0 | 0 | 62 |
USP1 protein, partial | 49 | 0 | 0 | 49 |
TDP1 protein | 82 | 0 | 0 | 82 |
vitamin D3 receptor isoform VDRA | 35 | 0 | 0 | 35 |
importin subunit beta-1 isoform 1 | 8 | 0 | 0 | 8 |
flap endonuclease 1 | 24 | 0 | 0 | 24 |
serine/threonine-protein kinase PLK1 | 7 | 0 | 0 | 7 |
snurportin-1 | 8 | 0 | 0 | 8 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 9 | 0 | 0 | 9 |
GTP-binding nuclear protein Ran isoform 1 | 7 | 0 | 0 | 7 |
DNA polymerase eta isoform 1 | 6 | 0 | 0 | 6 |
DNA polymerase iota isoform a (long) | 28 | 0 | 0 | 28 |
urokinase-type plasminogen activator precursor | 15 | 0 | 0 | 15 |
plasminogen precursor | 15 | 0 | 0 | 15 |
urokinase plasminogen activator surface receptor precursor | 15 | 0 | 0 | 15 |
geminin | 81 | 0 | 0 | 81 |
DNA polymerase kappa isoform 1 | 20 | 0 | 0 | 20 |
fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 1 |
Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 3 | 0 | 3 |
Transthyretin | 0 | 2 | 2 | 6 |
Fatty acid-binding protein, intestinal | 0 | 2 | 2 | 4 |
Fatty acid-binding protein, adipocyte | 0 | 2 | 2 | 4 |
Cyclin-A2 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 1 | 2 |
Cyclin-dependent kinase 2 | 0 | 1 | 2 | 3 |
Choline O-acetyltransferase | 0 | 2 | 0 | 2 |
Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 14 | 0 | 0 | 14 |
Fatty acid-binding protein 5 | 0 | 1 | 1 | 2 |
Fatty acid-binding protein 5 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase 11 | 0 | 1 | 1 | 2 |
Mitogen-activated protein kinase 14 | 0 | 1 | 1 | 2 |
Histone H2A.x | 28 | 0 | 0 | 28 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 65 | 0 | 0 | 65 |
Cellular tumor antigen p53 | 55 | 0 | 0 | 55 |
hypoxia-inducible factor 1 alpha subunit | 24 | 0 | 0 | 24 |
RAR-related orphan receptor gamma | 57 | 0 | 0 | 57 |
GLI family zinc finger 3 | 66 | 0 | 0 | 66 |
AR protein | 95 | 0 | 0 | 95 |
aldehyde dehydrogenase 1 family, member A1 | 50 | 0 | 0 | 50 |
retinoic acid nuclear receptor alpha variant 1 | 56 | 0 | 0 | 56 |
retinoid X nuclear receptor alpha | 52 | 0 | 0 | 52 |
estrogen nuclear receptor alpha | 100 | 0 | 0 | 100 |
peroxisome proliferator-activated receptor delta | 37 | 0 | 0 | 37 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 44 | 0 | 0 | 44 |
activating transcription factor 6 | 34 | 0 | 0 | 34 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 33 | 0 | 0 | 33 |
thyroid hormone receptor beta isoform a | 30 | 0 | 0 | 30 |
heat shock protein beta-1 | 25 | 0 | 0 | 25 |
lamin isoform A-delta10 | 78 | 0 | 0 | 78 |
Voltage-dependent calcium channel gamma-2 subunit | 33 | 0 | 0 | 33 |
Glutamate receptor 2 | 33 | 0 | 0 | 35 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 17 | 0 | 0 | 17 |
phosphopantetheinyl transferase | 29 | 0 | 0 | 29 |
bromodomain adjacent to zinc finger domain 2B | 17 | 0 | 0 | 17 |
euchromatic histone-lysine N-methyltransferase 2 | 83 | 0 | 0 | 83 |
pyruvate kinase PKM isoform a | 2 | 0 | 0 | 2 |
Glycoprotein hormones alpha chain | 2 | 0 | 0 | 2 |
Tubulin--tyrosine ligase | 0 | 2 | 0 | 2 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 45 | 0 | 0 | 45 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 28 | 0 | 0 | 28 |
Chain A, HADH2 protein | 25 | 0 | 0 | 25 |
Chain B, HADH2 protein | 25 | 0 | 0 | 25 |
Chain A, 2-oxoglutarate Oxygenase | 29 | 0 | 0 | 29 |
Chain A, Protocatechuate 3,4-dioxygenase | 0 | 0 | 1 | 1 |
Chain M, Protocatechuate 3,4-dioxygenase | 0 | 0 | 1 | 1 |
Olfactory receptor class A-like protein 1 | 0 | 0 | 1 | 1 |
Luciferase | 24 | 0 | 0 | 24 |
endonuclease IV | 14 | 0 | 0 | 14 |
RGS12 | 1 | 0 | 0 | 1 |
NFKB1 protein, partial | 19 | 0 | 0 | 19 |
GLS protein | 40 | 0 | 0 | 40 |
Microtubule-associated protein tau | 38 | 0 | 0 | 38 |
Thrombopoietin | 11 | 0 | 0 | 11 |
alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
thioredoxin glutathione reductase | 11 | 0 | 0 | 11 |
apical membrane antigen 1, AMA1 | 8 | 0 | 0 | 8 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 19 | 0 | 0 | 19 |
thyroid stimulating hormone receptor | 39 | 0 | 0 | 39 |
hypothetical protein, conserved | 8 | 0 | 0 | 8 |
regulator of G-protein signaling 4 | 38 | 0 | 0 | 38 |
Bloom syndrome protein isoform 1 | 30 | 0 | 0 | 30 |
lysosomal alpha-glucosidase preproprotein | 9 | 0 | 0 | 9 |
peripheral myelin protein 22 isoform 1 | 23 | 0 | 0 | 23 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 18 | 0 | 0 | 18 |
intestinal alkaline phosphatase precursor | 0 | 1 | 0 | 1 |
chromobox protein homolog 1 | 52 | 0 | 0 | 52 |
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase beta | 9 | 0 | 0 | 9 |
M-phase phosphoprotein 8 | 18 | 0 | 0 | 18 |
alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 2 | 2 |
muscarinic acetylcholine receptor M1 | 27 | 0 | 0 | 27 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 3 | 0 | 3 |
Sodium-dependent noradrenaline transporter | 0 | 15 | 2 | 17 |
Zinc finger protein mex-5 | 0 | 0 | 2 | 2 |
ATP-dependent phosphofructokinase | 37 | 0 | 0 | 37 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 2 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 9 | 2 | 12 |
5-hydroxytryptamine receptor 2A | 0 | 10 | 2 | 12 |
5-hydroxytryptamine receptor 1A | 0 | 30 | 6 | 37 |
5-hydroxytryptamine receptor 1B | 0 | 21 | 2 | 23 |
5-hydroxytryptamine receptor 1D | 0 | 4 | 2 | 6 |
5-hydroxytryptamine receptor 1F | 0 | 4 | 2 | 6 |
5-hydroxytryptamine receptor 2B | 0 | 8 | 2 | 10 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 2 | 3 |
Sodium-dependent serotonin transporter | 0 | 15 | 1 | 16 |
Sodium-dependent serotonin transporter | 0 | 7 | 0 | 8 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 2 | 3 |
Solute carrier organic anion transporter family member 2A1 | 0 | 4 | 0 | 11 |
Alpha-2A adrenergic receptor | 0 | 21 | 7 | 32 |
Alpha-1A adrenergic receptor | 0 | 4 | 3 | 7 |
Alpha-1B adrenergic receptor | 0 | 4 | 0 | 4 |
Alpha-2B adrenergic receptor | 0 | 16 | 6 | 22 |
Alpha-2C adrenergic receptor | 0 | 16 | 6 | 22 |
Alpha-2A adrenergic receptor | 0 | 16 | 6 | 22 |
Alpha-1D adrenergic receptor | 0 | 15 | 4 | 20 |
Alpha-1A adrenergic receptor | 0 | 12 | 9 | 28 |
Alpha-1B adrenergic receptor | 0 | 11 | 7 | 23 |
Alpha-1A adrenergic receptor | 0 | 22 | 5 | 27 |
Solute carrier family 22 member 1 | 0 | 21 | 0 | 34 |
Beta-2 adrenergic receptor | 0 | 21 | 13 | 35 |
Beta-1 adrenergic receptor | 0 | 26 | 10 | 36 |
Beta-3 adrenergic receptor | 0 | 13 | 10 | 23 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 28 | 0 | 0 | 28 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
GALC protein | 9 | 0 | 0 | 9 |
nuclear receptor subfamily 1, group I, member 3 | 49 | 0 | 0 | 49 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 44 | 0 | 0 | 44 |
glucocorticoid receptor [Homo sapiens] | 69 | 0 | 0 | 69 |
estrogen-related nuclear receptor alpha | 81 | 0 | 0 | 81 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
arylsulfatase A | 32 | 0 | 0 | 32 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
peripheral myelin protein 22 | 36 | 0 | 0 | 36 |
survival motor neuron protein isoform d | 31 | 0 | 0 | 31 |
muscleblind-like protein 1 isoform 1 | 12 | 0 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit pi | 35 | 5 | 5 | 45 |
ATP-binding cassette sub-family C member 3 | 0 | 61 | 0 | 61 |
Multidrug resistance-associated protein 4 | 0 | 61 | 0 | 65 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 11 | 0 | 12 |
Carbonic anhydrase 12 | 0 | 8 | 1 | 17 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
Bile salt export pump | 0 | 98 | 0 | 98 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 4 | 0 | 4 |
Carbonic anhydrase 1 | 0 | 23 | 1 | 35 |
Carbonic anhydrase 2 | 0 | 26 | 1 | 39 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 5 | 1 | 6 |
Carbonic anhydrase 3 | 0 | 8 | 1 | 15 |
Cathepsin B | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 16 | 2 | 19 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 5 | 0 | 5 |
Cytochrome P450 2C8 | 0 | 4 | 0 | 4 |
Cytochrome P450 2D6 | 0 | 11 | 1 | 12 |
Cytochrome P450 2A6 | 0 | 3 | 1 | 4 |
Cytochrome P450 2C9 | 0 | 23 | 0 | 23 |
Androgen receptor | 0 | 10 | 0 | 11 |
Gamma-aminobutyric acid receptor subunit beta-1 | 35 | 5 | 5 | 45 |
Translocator protein | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit delta | 35 | 5 | 5 | 45 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 35 | 5 | 5 | 45 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 35 | 5 | 5 | 45 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 35 | 5 | 5 | 45 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 1 | 2 |
Carbonic anhydrase 4 | 0 | 17 | 1 | 25 |
Carbonic anhydrase 6 | 0 | 11 | 1 | 19 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 35 | 5 | 5 | 45 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 35 | 5 | 5 | 45 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 7 | 1 | 12 |
Serum paraoxonase/arylesterase 1 | 0 | 3 | 0 | 3 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 35 | 5 | 5 | 45 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 35 | 5 | 5 | 45 |
Endochitinase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 35 | 5 | 5 | 45 |
Adenosine receptor A2a | 0 | 10 | 3 | 18 |
Delta-type opioid receptor | 0 | 8 | 0 | 9 |
Cytochrome P450 2C19 | 0 | 7 | 0 | 7 |
Delta-type opioid receptor | 0 | 9 | 2 | 12 |
Mu-type opioid receptor | 0 | 11 | 2 | 16 |
Carbonic anhydrase 5A, mitochondrial | 0 | 12 | 1 | 21 |
Carbonic anhydrase | 0 | 9 | 0 | 12 |
Kappa-type opioid receptor | 0 | 8 | 0 | 9 |
Carbonic anhydrase 7 | 0 | 9 | 1 | 17 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 8 | 2 | 0 | 10 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 5 |
D(2) dopamine receptor | 0 | 11 | 1 | 14 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 35 | 6 | 5 | 46 |
Gamma-aminobutyric acid receptor subunit beta-3 | 35 | 5 | 5 | 45 |
Gamma-aminobutyric acid receptor subunit beta-2 | 35 | 5 | 5 | 45 |
Cholinesterase | 0 | 4 | 0 | 4 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 8 | 1 | 9 |
Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
Beta-carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 7 | 2 | 12 |
Squalene synthase | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 5 | 2 | 8 |
Carbonic anhydrase 9 | 0 | 12 | 1 | 22 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase, alpha family | 0 | 3 | 0 | 3 |
Carbonic anhydrase | 0 | 1 | 0 | 5 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 7 |
Carbonic anhydrase | 0 | 1 | 0 | 6 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 3 | 0 | 3 |
Delta carbonic anhydrase | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 6 | 1 | 7 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 5 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 3 | 1 | 7 |
GABA theta subunit | 35 | 5 | 5 | 45 |
Canalicular multispecific organic anion transporter 1 | 0 | 56 | 0 | 57 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 15 | 0 | 9 | 0 | 13 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 8 | 0 | 14 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 35 | 5 | 5 | 45 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 8 | 1 | 17 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 9 | 1 | 18 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 11 | 0 | 0 | 11 |
acetylcholinesterase | 29 | 0 | 0 | 29 |
dopamine D1 receptor | 8 | 0 | 0 | 8 |
15-lipoxygenase, partial | 12 | 0 | 0 | 12 |
pregnane X receptor | 12 | 0 | 0 | 12 |
farnesoid X nuclear receptor | 43 | 0 | 0 | 43 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 46 | 0 | 0 | 46 |
D(1A) dopamine receptor | 18 | 0 | 0 | 18 |
thyroid hormone receptor beta isoform 2 | 56 | 0 | 0 | 56 |
Histone deacetylase 3 | 0 | 3 | 0 | 3 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Histone deacetylase 1 | 0 | 4 | 0 | 4 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Histone deacetylase 2 | 0 | 4 | 0 | 4 |
Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Ataxin-2 | 35 | 0 | 0 | 35 |
Histone deacetylase 8 | 0 | 2 | 0 | 2 |
Histone deacetylase 6 | 0 | 3 | 0 | 3 |
Histone deacetylase 9 | 0 | 1 | 0 | 1 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
Chain B, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
Chain A, tRNA (guanine-N(1)-)-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Uncharacterized protein MJ0883 | 0 | 0 | 1 | 1 |
signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
NPYLR7B | 0 | 0 | 3 | 3 |
IDH1 | 31 | 0 | 0 | 31 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
mitogen-activated protein kinase 1 | 27 | 0 | 0 | 27 |
nuclear receptor ROR-gamma isoform 1 | 29 | 0 | 0 | 29 |
high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
Calcium dependent protein kinase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
Rap guanine nucleotide exchange factor 3 | 9 | 0 | 0 | 9 |
Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 8 | 1 | 9 |
Phosphoglycerate kinase 1 | 0 | 1 | 0 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Avidin | 0 | 0 | 1 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Glyceraldehyde-3-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 4 | 0 | 4 |
Insulin receptor | 0 | 0 | 1 | 2 |
Phosphoglycerate kinase 2 | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 2 |
Platelet-derived growth factor receptor beta | 0 | 0 | 1 | 2 |
Adenosine receptor A3 | 0 | 12 | 3 | 16 |
Heat shock 70 kDa protein 1A | 0 | 1 | 0 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
Fibroblast growth factor receptor 1 | 0 | 0 | 1 | 2 |
Inosine-5'-monophosphate dehydrogenase 2 | 0 | 1 | 1 | 2 |
Endoplasmin | 0 | 1 | 1 | 2 |
Inosine-5'-monophosphate dehydrogenase 1 | 0 | 1 | 0 | 1 |
Fibroblast growth factor receptor 2 | 0 | 0 | 0 | 1 |
Fibroblast growth factor receptor 4 | 0 | 0 | 0 | 1 |
Fibroblast growth factor receptor 3 | 0 | 0 | 0 | 1 |
Streptavidin | 0 | 0 | 1 | 1 |
Adenosylhomocysteinase | 0 | 0 | 0 | 1 |
Adenosine receptor A3 | 0 | 3 | 0 | 3 |
Adenosine receptor A2a | 0 | 5 | 6 | 13 |
Adenosine receptor A2b | 0 | 1 | 1 | 4 |
Adenosine receptor A2b | 0 | 2 | 2 | 5 |
Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 8 | 3 | 14 |
Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 3 |
Adenosine receptor A1 | 0 | 2 | 1 | 3 |
Adenosine kinase | 0 | 0 | 1 | 2 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 3 |
Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0 | 1 | 0 | 1 |
Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 3 |
Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
Adenosine kinase | 0 | 1 | 0 | 2 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 3 |
5-methylthioadenosine/S-adenosylhomocysteine deaminase | 0 | 0 | 0 | 1 |
Adenosine transporter 1 | 0 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 27 | 0 | 0 | 27 |
Sex hormone-binding globulin | 0 | 0 | 4 | 4 |
Corticosteroid-binding globulin | 0 | 5 | 0 | 5 |
Mineralocorticoid receptor | 0 | 5 | 4 | 10 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 2 | 0 | 5 |
interleukin 8 | 13 | 0 | 0 | 13 |
estrogen receptor 2 (ER beta) | 36 | 0 | 0 | 36 |
progesterone receptor | 40 | 0 | 0 | 40 |
transcriptional regulator ERG isoform 3 | 5 | 0 | 0 | 5 |
ras-related protein Rab-9A | 15 | 0 | 0 | 15 |
Polyphenol oxidase 2 | 0 | 3 | 0 | 6 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 4 | 1 | 6 |
Purine nucleoside phosphorylase | 0 | 0 | 2 | 2 |
TAR DNA-binding protein 43 | 19 | 0 | 0 | 19 |
Shiga toxin subunit A | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 2 | 0 | 3 |
peroxisome proliferator activated receptor gamma | 49 | 0 | 0 | 49 |
Thromboxane-A synthase | 0 | 5 | 0 | 5 |
Prostaglandin E2 receptor EP3 subtype | 0 | 3 | 0 | 3 |
Prostaglandin E2 receptor EP4 subtype | 0 | 3 | 1 | 4 |
Prostaglandin E2 receptor EP1 subtype | 0 | 3 | 0 | 3 |
Prostacyclin receptor | 0 | 6 | 3 | 9 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 3 | 3 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 3 | 1 | 4 |
Solute carrier organic anion transporter family member 2A1 | 0 | 2 | 0 | 7 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 3 |
Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
SMAD family member 2 | 24 | 0 | 0 | 24 |
SMAD family member 3 | 24 | 0 | 0 | 24 |
pregnane X nuclear receptor | 55 | 0 | 0 | 55 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 25 | 0 | 0 | 25 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 3 | 1 | 4 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
Solute carrier organic anion transporter family member 1A3 | 0 | 3 | 0 | 5 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 3 |
ATAD5 protein, partial | 28 | 0 | 0 | 28 |
Fumarate hydratase | 19 | 0 | 0 | 19 |
PPM1D protein | 11 | 0 | 0 | 11 |
caspase 7, apoptosis-related cysteine protease | 8 | 0 | 0 | 8 |
EWS/FLI fusion protein | 35 | 0 | 0 | 35 |
G | 33 | 0 | 0 | 33 |
cytochrome P450 2D6 | 33 | 0 | 0 | 33 |
polyprotein | 19 | 0 | 0 | 19 |
caspase-3 | 8 | 0 | 0 | 8 |
thyroid stimulating hormone receptor | 26 | 0 | 0 | 26 |
cytochrome P450 2D6 isoform 1 | 15 | 0 | 0 | 15 |
cellular tumor antigen p53 isoform a | 16 | 0 | 0 | 16 |
cytochrome P450 2C9 precursor | 14 | 0 | 0 | 14 |
potassium voltage-gated channel subfamily H member 2 isoform d | 25 | 0 | 0 | 25 |
huntingtin isoform 2 | 7 | 0 | 0 | 7 |
serine/threonine-protein kinase mTOR isoform 1 | 13 | 0 | 0 | 13 |
cytochrome P450 3A4 isoform 1 | 35 | 0 | 0 | 35 |
lethal factor (plasmid) | 19 | 0 | 0 | 19 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 8 | 0 | 0 | 8 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 9 | 0 | 9 |
Solute carrier organic anion transporter family member 1A4 | 0 | 4 | 0 | 8 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 9 | 0 | 9 |
5-hydroxytryptamine receptor 4 | 0 | 16 | 1 | 17 |
Lysine-specific demethylase PHF2 | 0 | 1 | 0 | 1 |
Interferon beta | 42 | 0 | 0 | 42 |
HLA class I histocompatibility antigen, B alpha chain | 33 | 0 | 0 | 33 |
Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
Integrin beta-3 | 11 | 1 | 0 | 12 |
Tyrosine-protein kinase Fyn | 0 | 4 | 1 | 5 |
ATP-dependent translocase ABCB1 | 0 | 8 | 0 | 8 |
Aldo-keto reductase family 1 member B1 | 0 | 13 | 0 | 13 |
Muscarinic acetylcholine receptor M2 | 0 | 11 | 2 | 17 |
Muscarinic acetylcholine receptor M4 | 0 | 8 | 1 | 12 |
ATP-dependent translocase ABCB1 | 0 | 26 | 2 | 42 |
Integrin alpha-IIb | 11 | 1 | 0 | 12 |
Muscarinic acetylcholine receptor M5 | 0 | 8 | 1 | 12 |
Thyroid hormone receptor alpha | 0 | 3 | 3 | 6 |
Thyroid hormone receptor beta | 0 | 3 | 3 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 9 | 2 | 15 |
D(2) dopamine receptor | 0 | 12 | 1 | 14 |
Alpha-1B adrenergic receptor | 0 | 20 | 4 | 24 |
Lethal factor | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 18 | 3 | 25 |
Thyroid hormone receptor beta | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 10 | 2 | 15 |
ATP-dependent translocase ABCB1 | 0 | 8 | 0 | 9 |
Substance-K receptor | 0 | 4 | 0 | 4 |
D(1A) dopamine receptor | 0 | 11 | 1 | 14 |
D(4) dopamine receptor | 0 | 7 | 0 | 8 |
Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 7 | 2 | 9 |
Endothelin-1 receptor | 0 | 5 | 1 | 6 |
5-hydroxytryptamine receptor 2A | 0 | 13 | 1 | 14 |
5-hydroxytryptamine receptor 2C | 0 | 17 | 1 | 18 |
Lysine-specific demethylase 5A | 0 | 1 | 0 | 1 |
B2 bradykinin receptor | 0 | 4 | 1 | 7 |
Melanocortin receptor 4 | 0 | 4 | 0 | 4 |
C-8 sterol isomerase | 0 | 2 | 0 | 2 |
Melanocortin receptor 5 | 0 | 4 | 0 | 4 |
Mu-type opioid receptor | 0 | 12 | 3 | 16 |
D(3) dopamine receptor | 0 | 13 | 0 | 14 |
Sodium channel protein type 1 subunit alpha | 0 | 5 | 0 | 5 |
Sodium channel protein type 4 subunit alpha | 0 | 8 | 0 | 11 |
Squalene synthase | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 9 | 2 | 12 |
Kappa-type opioid receptor | 0 | 9 | 2 | 12 |
5-hydroxytryptamine receptor 2B | 0 | 16 | 1 | 17 |
C-C chemokine receptor type 2 | 0 | 4 | 0 | 4 |
Melanocortin receptor 3 | 0 | 4 | 0 | 4 |
Histamine H2 receptor | 19 | 0 | 2 | 23 |
5-hydroxytryptamine receptor 6 | 0 | 10 | 1 | 11 |
Carnitine O-palmitoyltransferase 1, liver isoform | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 4 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 32 | 1 | 3 | 36 |
Sodium channel protein type 7 subunit alpha | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 9 | 0 | 9 |
Sodium-dependent dopamine transporter | 0 | 17 | 0 | 17 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 30 | 0 | 30 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 9 | 0 | 9 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 14 | 0 | 15 |
Sodium channel protein type 5 subunit alpha | 0 | 9 | 0 | 9 |
Squalene monooxygenase | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 8 | 0 | 8 |
Lysine-specific demethylase 7A | 0 | 1 | 0 | 1 |
Carnitine O-palmitoyltransferase 1, muscle isoform | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 33 | 0 | 0 | 33 |
Sodium channel protein type 2 subunit alpha | 0 | 6 | 0 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 19 | 1 | 20 |
NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 0 | 1 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 7 | 0 | 7 |
Sodium channel protein type 11 subunit alpha | 0 | 3 | 0 | 3 |
Histone lysine demethylase PHF8 | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 10 subunit alpha | 0 | 4 | 0 | 4 |
cytochrome P450 2C9, partial | 33 | 0 | 0 | 33 |
Chain A, Ferritin light chain | 20 | 0 | 0 | 20 |
Smad3 | 19 | 0 | 0 | 19 |
NEDD8-activating enzyme E1 regulatory subunit isoform a | 0 | 1 | 0 | 1 |
NEDD8-conjugating enzyme Ubc12 | 0 | 1 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 26 | 0 | 0 | 26 |
Potassium channel subfamily K member 2 | 0 | 4 | 5 | 9 |
Alpha-2C adrenergic receptor | 0 | 16 | 6 | 26 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 6 | 0 | 7 |
Alpha-1D adrenergic receptor | 0 | 23 | 6 | 34 |
Potassium channel subfamily K member 2 | 0 | 2 | 0 | 2 |
Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
Chain A, Cruzipain | 18 | 0 | 0 | 18 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase type 2 | 0 | 1 | 1 | 4 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 3 |
60 kDa heat shock protein, mitochondrial | 0 | 5 | 0 | 5 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 7 | 0 | 7 |
Solute carrier family 15 member 1 | 0 | 4 | 0 | 4 |
10 kDa heat shock protein, mitochondrial | 0 | 5 | 0 | 5 |
Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
Thiosulfate sulfurtransferase | 0 | 4 | 0 | 4 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 2 |
Efflux transporter | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Class D beta-lactamase | 0 | 0 | 0 | 2 |
60 kDa chaperonin | 0 | 5 | 0 | 5 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 4 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
10 kDa chaperonin | 0 | 5 | 0 | 5 |
Metallo-b-lactamase | 0 | 0 | 0 | 3 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 3 |
Beta-lactamase class B VIM-2 | 0 | 1 | 1 | 5 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 2 |
67.9K protein | 20 | 0 | 0 | 20 |
Replicase polyprotein 1ab | 0 | 9 | 3 | 12 |
Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 2 |
Signal transducer and activator of transcription 3 | 0 | 0 | 1 | 1 |
Hexokinase-2 | 0 | 1 | 0 | 1 |
Bile acid receptor | 0 | 3 | 0 | 3 |
glucocerebrosidase | 11 | 0 | 0 | 11 |
Atrial natriuretic peptide receptor 3 | 0 | 2 | 0 | 2 |
Type-1A angiotensin II receptor | 0 | 8 | 5 | 13 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 9 | 1 | 10 |
Type-1 angiotensin II receptor | 0 | 13 | 5 | 23 |
Type-2 angiotensin II receptor | 0 | 9 | 1 | 10 |
Type-2 angiotensin II receptor | 0 | 9 | 0 | 9 |
neuropeptide S receptor isoform A | 12 | 0 | 0 | 12 |
Chain A, Xaa-Pro aminopeptidase | 0 | 1 | 0 | 1 |
Xaa-Pro aminopeptidase 2 | 0 | 1 | 0 | 1 |
Xaa-Pro dipeptidase | 0 | 1 | 0 | 1 |
Cytosol aminopeptidase | 0 | 1 | 0 | 1 |
Xaa-Pro aminopeptidase 2 | 0 | 1 | 0 | 1 |
Xaa-Pro aminopeptidase 1 | 0 | 1 | 0 | 1 |
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 11 | 0 | 0 | 11 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 6 | 0 | 0 | 6 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 6 | 0 | 0 | 6 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 0 | 0 | 2 |
caspase-1 isoform alpha precursor | 3 | 0 | 0 | 3 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 5 |
Trypsin | 0 | 1 | 0 | 1 |
Coagulation factor VII | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 3 | 0 | 3 |
Aromatase | 0 | 3 | 0 | 3 |
Tissue factor | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 13 | 2 | 16 |
Calmodulin | 0 | 1 | 1 | 3 |
Disintegrin and metalloproteinase domain-containing protein 17 | 4 | 0 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 5 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 11 | 0 | 14 |
Cytosolic phospholipase A2 gamma | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 17 | 0 | 21 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
alpha-galactosidase | 8 | 0 | 0 | 8 |
cytochrome P450 2C19 precursor | 12 | 0 | 0 | 12 |
Nitric oxide synthase, endothelial | 0 | 3 | 0 | 5 |
Nitric oxide synthase, brain | 0 | 6 | 0 | 7 |
Nitric oxide synthase, brain | 0 | 3 | 0 | 5 |
Nitric oxide synthase, inducible | 0 | 5 | 0 | 6 |
Nitric oxide synthase, inducible | 0 | 4 | 1 | 8 |
Cationic amino acid transporter 3 | 0 | 2 | 0 | 2 |
Vasopressin V2 receptor | 0 | 3 | 2 | 6 |
Oxytocin receptor | 0 | 1 | 2 | 3 |
Vasopressin V1a receptor | 0 | 0 | 3 | 3 |
Vasopressin V1a receptor | 0 | 5 | 3 | 8 |
Vasopressin V1b receptor | 0 | 2 | 2 | 4 |
Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
Vasopressin V1b receptor | 0 | 1 | 1 | 3 |
Translocator protein | 0 | 2 | 0 | 3 |
Oxytocin receptor | 0 | 1 | 1 | 2 |
Vasopressin V2 receptor | 0 | 2 | 2 | 4 |
Neutral amino acid transporter A | 0 | 3 | 0 | 3 |
Neutral amino acid transporter B(0) | 0 | 3 | 0 | 3 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 4 |
Amino acid transporter | 0 | 3 | 0 | 3 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
Rac1 protein | 0 | 0 | 1 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
Prostaglandin-H2 D-isomerase | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 4 |
Fatty acid-binding protein, liver | 0 | 5 | 1 | 6 |
Myeloperoxidase | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 5 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 11 | 0 | 11 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 14 | 1 | 1 | 16 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
Nicotinate phosphoribosyltransferase | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 20 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 5 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
Beta-1 adrenergic receptor | 0 | 1 | 8 | 11 |
Urease | 0 | 2 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 2 | 8 | 12 |
Caspase-7 | 5 | 0 | 0 | 5 |
caspase-3 | 5 | 0 | 0 | 5 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 4 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 4 | 0 | 4 |
Insulin receptor | 0 | 2 | 0 | 2 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 11 | 1 | 13 |
Amine oxidase [flavin-containing] A | 0 | 1 | 2 | 3 |
Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 1 | 2 |
Atrial natriuretic peptide receptor 1 | 0 | 1 | 1 | 2 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 2 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 7 | 2 | 11 |
Muscarinic acetylcholine receptor M3 | 0 | 5 | 2 | 9 |
Muscarinic acetylcholine receptor M4 | 0 | 6 | 2 | 10 |
Muscarinic acetylcholine receptor M5 | 0 | 5 | 2 | 9 |
Muscarinic acetylcholine receptor M2 | 0 | 5 | 2 | 10 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 9 | 0 | 10 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
Neuronal acetylcholine receptor subunit alpha-4 | 3 | 4 | 2 | 10 |
Neuronal acetylcholine receptor subunit beta-2 | 3 | 4 | 2 | 10 |
Thromboxane A2 receptor | 0 | 2 | 1 | 6 |
Sodium/bile acid cotransporter | 0 | 4 | 0 | 4 |
Multidrug and toxin extrusion protein 1 | 0 | 14 | 0 | 14 |
Leukotriene B4 receptor 2 | 0 | 1 | 2 | 4 |
P53 | 2 | 0 | 0 | 2 |
aryl hydrocarbon receptor | 31 | 0 | 0 | 31 |
hemoglobin subunit beta | 3 | 0 | 0 | 3 |
Bile salt export pump | 0 | 15 | 0 | 15 |
ATPase family AAA domain-containing protein 5 | 22 | 0 | 0 | 22 |
Protein-arginine deiminase type-4 | 0 | 4 | 0 | 4 |
glp-1 receptor, partial | 23 | 0 | 0 | 23 |
nonstructural protein 1 | 14 | 0 | 0 | 14 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 3 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 5 | 5 |
Rap guanine nucleotide exchange factor 4 | 4 | 0 | 0 | 4 |
Angiotensin-converting enzyme | 0 | 11 | 1 | 13 |
Angiotensin-converting enzyme | 0 | 17 | 0 | 18 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 7 | 0 | 7 |
nuclear receptor subfamily 1, group I, member 2 | 9 | 0 | 0 | 9 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 12 | 3 | 20 |
Glycine receptor subunit alpha-1 | 0 | 12 | 0 | 12 |
Glycine receptor subunit beta | 0 | 12 | 0 | 12 |
Glycine receptor subunit alpha-2 | 0 | 12 | 0 | 12 |
Glycine receptor subunit alpha-3 | 0 | 12 | 0 | 12 |
ORF73 | 0 | 0 | 3 | 3 |
Caspase-7 | 2 | 0 | 0 | 2 |
Inositol monophosphatase 1 | 15 | 0 | 0 | 15 |
Beta-1 adrenergic receptor | 0 | 4 | 1 | 5 |
Alpha-1A adrenergic receptor | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 1A | 0 | 8 | 2 | 10 |
B2 bradykinin receptor | 0 | 1 | 0 | 1 |
B1 bradykinin receptor | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 3 | 3 |
Solute carrier family 12 member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 3 | 0 | 3 | 0 | 3 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
ClpP | 4 | 0 | 0 | 4 |
electroneutral potassium-chloride cotransporter KCC2 | 0 | 0 | 1 | 1 |
TSHR protein | 2 | 0 | 0 | 2 |
Parkin | 11 | 0 | 0 | 11 |
LacZ protein (plasmid) | 0 | 0 | 1 | 1 |
XBP1 | 0 | 1 | 0 | 1 |
serine-protein kinase ATM isoform a | 3 | 0 | 0 | 3 |
hexokinase-4 isoform 1 | 3 | 0 | 0 | 3 |
NPC intracellular cholesterol transporter 1 precursor | 9 | 0 | 0 | 9 |
type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 11 | 0 | 0 | 11 |
glucokinase regulatory protein | 3 | 0 | 0 | 3 |
apelin receptor | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 5 |
DNA damage-inducible transcript 3 protein | 0 | 1 | 0 | 1 |
Vpr | 8 | 0 | 0 | 8 |
streptokinase A precursor | 0 | 0 | 3 | 3 |
Amyloid-beta precursor protein | 2 | 4 | 0 | 6 |
Alpha-synuclein | 7 | 1 | 0 | 8 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 2 |
heat shock protein 90, putative | 0 | 0 | 0 | 5 |
Type-1 angiotensin II receptor | 0 | 3 | 1 | 4 |
transient receptor potential cation channel subfamily V member 1 | 2 | 0 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 3 | 1 | 4 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
NADH-ubiquinone oxidoreductase chain 1 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 7 | 0 | 7 |
Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 3 | 1 | 4 |
Corticotropin-releasing factor receptor 2 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 1 | 4 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 0 | 1 | 1 |
Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 1 | 1 | 2 |
Neprilysin | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 2 | 0 | 2 |
Leukotriene A-4 hydrolase | 0 | 4 | 1 | 5 |
EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 1 | 2 |
Endothelin-converting enzyme 1 | 0 | 1 | 0 | 1 |
Succinyl-diaminopimelate desuccinylase | 0 | 3 | 0 | 3 |
Beta-lactamase TEM | 0 | 2 | 0 | 4 |
Beta-lactamase | 0 | 2 | 0 | 3 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme 2 | 0 | 4 | 3 | 7 |
Albumin | 0 | 0 | 3 | 3 |
Major prion protein | 0 | 0 | 2 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 2 subunit alpha | 0 | 4 | 0 | 4 |
Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 3 |
Cytochrome P450 2J2 | 0 | 13 | 0 | 13 |
Frizzled-8 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 4 | 0 | 0 | 4 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 7 | 0 | 12 |
UDP-glucuronosyltransferase 1A1 | 0 | 4 | 0 | 4 |
Potassium channel subfamily K member 10 | 0 | 1 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 8 | 0 | 8 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 6 | 6 |
Solute carrier family 22 member 5 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
Beta-lactamase OXA-10 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 6 | 0 | 11 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 2 | 0 | 6 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 6 | 0 | 9 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 22 member 11 | 0 | 1 | 0 | 3 |
Solute carrier family 22 member 8 | 0 | 3 | 0 | 5 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 3 |
thyrotropin-releasing hormone receptor | 6 | 0 | 0 | 6 |
Caspase-2 | 0 | 0 | 1 | 1 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Methionine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
NADPH oxidase 1 | 0 | 1 | 0 | 1 |
Snq2p | 0 | 0 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 0 | 1 | 3 | 4 |
Replicase polyprotein 1ab | 0 | 1 | 3 | 4 |
histone deacetylase 9 isoform 3 | 5 | 0 | 0 | 5 |
atrial natriuretic peptide receptor 2 precursor | 4 | 0 | 0 | 4 |
Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 1 | 3 | 4 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Albumin | 0 | 8 | 6 | 14 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 2 | 0 | 2 |
Major prion protein | 0 | 0 | 1 | 1 |
Procathepsin L | 0 | 3 | 3 | 6 |
Replicase polyprotein 1a | 0 | 1 | 3 | 4 |
Replicase polyprotein 1ab | 0 | 1 | 3 | 4 |
Replicase polyprotein 1ab | 0 | 5 | 3 | 8 |
Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 2 | 1 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 7 | 0 | 7 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
D | 0 | 8 | 0 | 10 |
D(3) dopamine receptor | 0 | 7 | 0 | 7 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
D(1B) dopamine receptor | 0 | 3 | 0 | 4 |
Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A4 | 0 | 2 | 0 | 3 |
Sodium-dependent dopamine transporter | 0 | 5 | 0 | 5 |
D(1B) dopamine receptor | 0 | 4 | 0 | 4 |
Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 4 | 0 | 4 |
Histamine H1 receptor | 0 | 2 | 3 | 5 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 1 | 3 |
Histamine H1 receptor | 0 | 6 | 2 | 8 |
Glutamate receptor ionotropic, NMDA 1 | 1 | 7 | 2 | 13 |
Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 0 | 1 | 2 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 6 | 2 | 11 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 6 | 2 | 11 |
Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 0 | 3 |
Aldehyde oxidase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 6 | 2 | 11 |
Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 6 | 2 | 11 |
D | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 6 | 2 | 11 |
Histamine H3 receptor | 0 | 2 | 2 | 4 |
PINK1 | 3 | 0 | 0 | 3 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 4 | 0 | 0 | 4 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 3 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein | 0 | 0 | 1 | 1 |
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Choline-binding protein | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 4 | 0 | 6 |
Solute carrier family 22 member 2 | 0 | 3 | 0 | 4 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 3 | 2 | 6 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 3 | 2 | 6 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 3 | 2 | 6 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 3 | 2 | 6 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 3 | 2 | 6 |
Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
Choline O-acetyltransferase | 0 | 1 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 3 | 2 | 6 |
Neuronal acetylcholine receptor subunit alpha-9 | 0 | 3 | 2 | 6 |
Solute carrier family 22 member 1 | 0 | 13 | 0 | 17 |
High affinity choline transporter 1 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-10 | 0 | 3 | 2 | 6 |
Solute carrier family 22 member 2 | 0 | 12 | 0 | 15 |
Beta-2 adrenergic receptor | 0 | 1 | 3 | 6 |
Peroxisome proliferator-activated receptor alpha | 0 | 0 | 2 | 2 |
Peroxisome proliferator-activated receptor gamma | 0 | 2 | 7 | 9 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
Peroxisome proliferator-activated receptor alpha | 1 | 1 | 2 | 4 |
Alpha-1B adrenergic receptor | 0 | 0 | 3 | 3 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 3 | 0 | 9 | 0 | 10 |
Amine oxidase [flavin-containing] A | 0 | 4 | 0 | 5 |
Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 4 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 3 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 3 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Nischarin | 0 | 2 | 0 | 2 |
Nischarin | 0 | 2 | 0 | 2 |
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 4 | 0 | 4 |
Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 4 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 5 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 4 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 6 | 0 | 6 |
Leukotriene B4 receptor 1 | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 4 | 0 | 4 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 4 | 0 | 4 |
Transporter | 0 | 3 | 1 | 5 |
Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
Histone acetyltransferase KAT2B | 0 | 1 | 0 | 1 |
Histone acetyltransferase KAT5 | 0 | 1 | 0 | 1 |
N-alpha-acetyltransferase 50 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 3 |
atrial natriuretic peptide receptor 1 precursor | 7 | 0 | 0 | 7 |
Phosphodiesterase | 0 | 3 | 0 | 3 |
Multidrug resistance-associated protein 5 | 0 | 0 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 7 | 0 | 7 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 7 | 0 | 7 |
RPL19A | 0 | 0 | 1 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 4 | 0 | 0 | 4 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
COUP transcription factor 2 isoform a | 0 | 1 | 0 | 1 |
Glucose transporter | 0 | 1 | 0 | 1 |
Hexose transporter 1 | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
Eukaryotic initiation factor 4A-I | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 4 | 1 | 5 |
Peptidyl-prolyl cis-trans isomerase FKBP3 | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP4 | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 1 | 0 | 1 |
Hypoxia-inducible factor 1-alpha | 0 | 1 | 0 | 1 |
Endothelial PAS domain-containing protein 1 | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP14 | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 | 0 | 1 | 0 | 1 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
Hsf1 protein | 0 | 0 | 4 | 4 |
Glutamate receptor 1 | 1 | 0 | 0 | 3 |
Glutamate receptor 3 | 1 | 0 | 0 | 3 |
Glutamate receptor 4 | 1 | 0 | 0 | 3 |
Nicotinamide phosphoribosyltransferase | 0 | 0 | 1 | 1 |
ATP-binding cassette sub-family C member 8 | 0 | 2 | 1 | 3 |
ATP-sensitive inward rectifier potassium channel 11 | 0 | 2 | 1 | 3 |
NAD | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 3 | 0 | 3 |
NAD | 0 | 1 | 0 | 2 |
Mitogen-activated protein kinase 1 | 0 | 1 | 1 | 2 |
ATP phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 2 | 0 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 2 |
Integrase | 0 | 2 | 0 | 2 |
G-protein coupled receptor 35 | 0 | 2 | 2 | 4 |
STAT3, partial | 0 | 3 | 0 | 3 |
signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 3 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 5 | 0 | 6 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 5 | 0 | 6 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 3 | 0 | 4 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 3 | 0 | 4 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 5 | 0 | 6 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 3 | 0 | 4 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 3 | 0 | 4 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 3 | 0 | 4 |
Solute carrier organic anion transporter family member 4C1 | 0 | 2 | 0 | 5 |
PAX8 | 0 | 0 | 0 | 2 |
tumor necrosis factor | 2 | 0 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Cereblon isoform 4 | 0 | 2 | 0 | 2 |
Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
Protein cereblon | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 3 | 3 | 6 |
Prostaglandin E2 receptor EP4 subtype | 0 | 3 | 1 | 4 |
Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
Prostaglandin F2-alpha receptor | 0 | 2 | 2 | 4 |
Prostaglandin E2 receptor EP3 subtype | 0 | 4 | 2 | 6 |
Prostaglandin E2 receptor EP2 subtype | 0 | 3 | 2 | 5 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin D2 receptor | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 2A1 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 4 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 2 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 2 | 2 |
Tyrosine-protein kinase Lck | 0 | 1 | 1 | 2 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 2 |
Ornithine decarboxylase | 1 | 1 | 0 | 2 |
Mitochondrial 2-oxodicarboxylate carrier | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 1 | 3 |
chaperonin-containing TCP-1 beta subunit homolog | 3 | 0 | 0 | 3 |
eyes absent homolog 2 isoform a | 3 | 0 | 0 | 3 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
large T antigen | 0 | 2 | 0 | 2 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Luciferin 4-monooxygenase | 0 | 1 | 1 | 2 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 2 | 0 | 4 |
Tyrosine-protein phosphatase 1 | 0 | 1 | 0 | 1 |
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 0 | 2 | 0 | 2 |
Vesicular glutamate transporter 3 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 4 | 1 | 6 |
Mu-type opioid receptor | 0 | 3 | 1 | 6 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
Alpha-glucosidase MAL12 | 0 | 1 | 0 | 1 |
Hyaluronidase-1 | 0 | 1 | 0 | 1 |
Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 3 |
Thymidylate synthase | 0 | 2 | 0 | 3 |
Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 4 |
Multidrug resistance associated protein | 0 | 0 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 4 | 0 | 4 |
Thymidine kinase | 0 | 2 | 0 | 3 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
Transitional endoplasmic reticulum ATPase | 0 | 1 | 0 | 1 |
DNA topoisomerase 1 | 0 | 2 | 0 | 2 |
DNA topoisomerase 2-alpha | 0 | 1 | 1 | 2 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 2 | 3 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 1 | 2 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 1 | 2 |
ATP-binding cassette sub-family C member 9 | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 2 | 0 | 2 |
ATP synthase subunit beta, mitochondrial | 0 | 1 | 0 | 1 |
ATP synthase subunit delta, mitochondrial | 0 | 1 | 0 | 1 |
ATP synthase subunit gamma, mitochondrial | 0 | 1 | 0 | 1 |
ATP synthase subunit epsilon, mitochondrial | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 1 | 1 | 2 |
Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
Malate dehydrogenase, cytoplasmic | 0 | 2 | 0 | 2 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 5 | 0 | 6 |
Proton-coupled amino acid transporter 1 | 0 | 4 | 0 | 5 |
Serine racemase | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Plasma kallikrein | 0 | 0 | 0 | 3 |
Macrophage migration inhibitory factor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 2 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 3 | 0 | 4 |
pyruvate kinase | 2 | 0 | 0 | 2 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
Aspartate aminotransferase, cytoplasmic | 0 | 1 | 0 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Cyclic GMP-AMP synthase | 0 | 1 | 0 | 1 |
Toll-like receptor 9 | 0 | 1 | 0 | 1 |
Toll-like receptor 7 | 0 | 1 | 0 | 1 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 2 | 0 | 2 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 0 | 2 | 2 |
Urease subunit alpha | 0 | 2 | 0 | 2 |
Ribonucleoside-diphosphate reductase large subunit | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 2 | 0 | 2 |
Prostacyclin receptor | 0 | 1 | 1 | 2 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 2 | 0 | 2 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
Interleukin-8 | 0 | 2 | 0 | 2 |
Androgen receptor | 0 | 7 | 2 | 9 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 2 |
Caspase-1 | 0 | 1 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 1 | 0 | 3 | 1 | 6 |
Bifunctional epoxide hydrolase 2 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
C-X-C chemokine receptor type 3 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Lactoylglutathione lyase | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
Peptidylglycine alpha-amidating monooxygenase | 0 | 0 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
beta-2 adrenergic receptor | 5 | 0 | 0 | 5 |
Beta-2 adrenergic receptor | 0 | 4 | 1 | 7 |
Beta-1 adrenergic receptor | 0 | 8 | 3 | 14 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 3 | 3 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 3 | 1 | 4 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 2 | 3 |
Taste receptor type 2 member 13 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 2 | 0 | 0 | 2 |
Caspase-3 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Cell division control protein 42 homolog | 0 | 1 | 0 | 1 |
Ras-related C3 botulinum toxin substrate 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
Heparanase | 0 | 0 | 1 | 1 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 2 | 0 | 2 |
Chain A, AMINOPEPTIDASE | 0 | 2 | 0 | 2 |
Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 4 | 0 | 4 |
Intestinal-type alkaline phosphatase | 0 | 3 | 0 | 3 |
Phospholipase A-2-activating protein | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 3 | 0 | 3 |
Platelet glycoprotein VI | 0 | 1 | 1 | 3 |
Type-1 angiotensin II receptor | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 5 | 0 | 6 |
heat shock 70kDa protein 1A | 0 | 1 | 0 | 1 |
glyceraldehyde-3-phosphate dehydrogenase isoform 1 | 0 | 1 | 0 | 1 |
heat shock cognate 71 kDa protein isoform 1 | 0 | 1 | 0 | 1 |
dual specificity protein phosphatase 6 | 0 | 1 | 0 | 1 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
heat shock cognate 71 kDa protein isoform 2 | 0 | 1 | 0 | 1 |
Glutathione S-transferase Mu 1 | 0 | 1 | 0 | 1 |
Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain A, Aminopeptidase | 0 | 1 | 0 | 1 |
Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
S-ribosylhomocysteine lyase | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 1 | 0 | 2 |
S-adenosylmethionine synthase isoform type-1 | 0 | 0 | 0 | 1 |
S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 0 | 1 |
Fatty acid synthase | 0 | 1 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 3 |
estrogen receptor beta isoform 1 | 0 | 2 | 0 | 2 |
Cystathionine gamma-lyase | 0 | 2 | 0 | 2 |
phosphoglycerate kinase | 2 | 0 | 0 | 2 |
Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
T cell receptor, partial | 1 | 0 | 0 | 1 |
luteinizing hormone receptor | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
luciferase | 1 | 0 | 0 | 1 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 1 | 2 |
Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
Cruzipain | 0 | 1 | 0 | 1 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 2B10 | 0 | 2 | 0 | 2 |
Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Nuclear receptor corepressor 2 | 0 | 1 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 0 | 0 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 0 | 0 | 1 |
Neuropeptide Y receptor type 1 | 0 | 2 | 0 | 2 |
Neuropeptide Y receptor type 2 | 0 | 2 | 0 | 2 |
Neutrophil elastase | 0 | 2 | 0 | 2 |
Nitric oxide synthase, endothelial | 0 | 4 | 0 | 4 |
Collagenase 3 | 0 | 2 | 0 | 2 |
Equilibrative nucleoside transporter 1 | 0 | 1 | 0 | 1 |
B2 bradykinin receptor | 0 | 1 | 0 | 1 |
Quinolone resistance protein NorA | 0 | 2 | 0 | 3 |
5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta-like 2 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 2 | 4 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 1 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Acetylcholine-binding protein | 0 | 1 | 1 | 2 |
Acetylcholine receptor subunit epsilon | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 1 | 2 |
Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
Liver carboxylesterase B-1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Soluble acetylcholine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Integrin beta | 0 | 0 | 1 | 1 |
Glycoprotein IIb | 0 | 0 | 1 | 1 |
perilipin-5 | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 5 | 0 | 5 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 1 | 2 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Interstitial collagenase | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit beta-4 | 0 | 1 | 0 | 1 |
Voltage-dependent P/Q-type calcium channel subunit alpha-1A | 0 | 1 | 0 | 1 |
Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-3 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent T-type calcium channel subunit alpha-1H | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit beta-3 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-7 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit beta-1 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-1 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit beta-2 | 0 | 1 | 0 | 1 |
Voltage-dependent R-type calcium channel subunit alpha-1E | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-4 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-3 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-8 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-6 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
Voltage-dependent T-type calcium channel subunit alpha-1I | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-4 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-5 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 0 | 1 | 0 | 1 |
Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 2 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
Chain H, Igg2b-kappa 40-50 Fab (heavy Chain) | 0 | 1 | 0 | 1 |
Chain L, Igg2b-kappa 40-50 Fab (light Chain) | 0 | 1 | 0 | 1 |
Chain A, Na, K-ATPase alpha subunit | 0 | 0 | 1 | 1 |
Kruppel-like factor 5 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 3 | 0 | 3 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 3 | 0 | 3 |
Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
Serine hydroxymethyltransferase, mitochondrial | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 3 | 0 | 3 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 3 | 0 | 3 |
CREB-binding protein | 1 | 0 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 2 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
Beta-lactamase 1 | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
E3 ubiquitin-protein ligase XIAP | 0 | 1 | 0 | 1 |
SLC16A10 protein | 0 | 0 | 0 | 2 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 2 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Complement C1s subcomponent | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 4 | 1 | 5 |
Prostacyclin synthase | 0 | 1 | 0 | 1 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
interferon gamma precursor | 0 | 0 | 0 | 1 |
Beta-casein | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 1 | 1 | 2 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-mannosidase 2C1 | 0 | 0 | 1 | 1 |
Bromodomain-containing protein 2 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
luciferase | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 4 | 1 | 5 |
Progesterone receptor | 0 | 4 | 1 | 6 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 3 | 1 | 4 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 4 | 0 | 2 | 0 | 2 |
DNA (cytosine-5)-methyltransferase 3-like | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 3A | 0 | 1 | 0 | 1 |
Glutamate 5-kinase | 0 | 0 | 0 | 1 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
Multidrug resistance protein 1a | 0 | 0 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
Chromaffin granule amine transporter | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 2 | 1 | 3 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Estrogen receptor | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 1 | 2 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 1 | 2 |
Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 9 | 0 | 1 | 0 | 1 |
D(1) dopamine receptor | 0 | 1 | 0 | 1 |
Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 7 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 1 | 0 | 2 |
D | 0 | 1 | 0 | 1 |
Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
photoreceptor-specific nuclear receptor | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Bone morphogenetic protein receptor type-1B | 0 | 0 | 1 | 1 |
Cell division cycle 7-related protein kinase | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase PLK4 | 0 | 0 | 1 | 1 |
ATP-dependent RNA helicase DDX3X | 0 | 0 | 1 | 1 |
Pyridoxal kinase | 0 | 0 | 1 | 1 |
Citron Rho-interacting kinase | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase Chk1 | 0 | 0 | 1 | 1 |
Aurora kinase A | 0 | 0 | 1 | 1 |
Cyclin-G-associated kinase | 0 | 0 | 1 | 1 |
Ephrin type-B receptor 6 | 0 | 0 | 1 | 1 |
Peroxisomal acyl-coenzyme A oxidase 3 | 0 | 0 | 1 | 1 |
Receptor-interacting serine/threonine-protein kinase 2 | 0 | 0 | 1 | 1 |
Mitotic checkpoint serine/threonine-protein kinase BUB1 | 0 | 0 | 1 | 1 |
Dynamin-like 120 kDa protein, mitochondrial | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase JAK2 | 0 | 0 | 1 | 1 |
Eukaryotic translation initiation factor 5B | 0 | 0 | 1 | 1 |
Rho-associated protein kinase 2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase ULK1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase/endoribonuclease IRE1 | 0 | 0 | 1 | 1 |
Ribosomal protein S6 kinase alpha-5 | 0 | 0 | 1 | 1 |
U5 small nuclear ribonucleoprotein 200 kDa helicase | 0 | 0 | 1 | 1 |
Ribosomal protein S6 kinase alpha-4 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 16 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase-like 5 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 10 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase D3 | 0 | 0 | 2 | 2 |
Structural maintenance of chromosomes protein 2 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 6 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase kinase 4 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase LATS1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase PAK 4 | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
High affinity nerve growth factor receptor | 0 | 0 | 1 | 1 |
ADP/ATP translocase 2 | 0 | 0 | 1 | 1 |
Protein kinase C beta type | 0 | 1 | 2 | 3 |
Cyclin-dependent kinase 1 | 0 | 0 | 1 | 1 |
Eukaryotic translation initiation factor 4E | 0 | 0 | 1 | 1 |
Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Fes/Fps | 0 | 0 | 1 | 1 |
Adenine phosphoribosyltransferase | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Yes | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Lyn | 0 | 0 | 1 | 1 |
Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 0 | 1 | 1 |
Insulin-like growth factor 1 receptor | 0 | 0 | 1 | 1 |
Signal recognition particle receptor subunit alpha | 0 | 0 | 1 | 1 |
Cytochrome c1, heme protein, mitochondrial | 0 | 0 | 1 | 1 |
Hepatocyte growth factor receptor | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase HCK | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Fgr | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase A-Raf | 0 | 0 | 1 | 1 |
Glycogen phosphorylase, brain form | 0 | 0 | 1 | 1 |
Breakpoint cluster region protein | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase pim-1 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 4 | 0 | 0 | 1 | 1 |
ADP/ATP translocase 3 | 0 | 0 | 1 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 0 | 1 | 1 |
cAMP-dependent protein kinase type II-alpha regulatory subunit | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase B-raf | 0 | 0 | 1 | 1 |
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Fer | 0 | 0 | 1 | 1 |
Protein kinase C alpha type | 0 | 1 | 2 | 3 |
cAMP-dependent protein kinase catalytic subunit alpha | 0 | 0 | 1 | 1 |
General transcription and DNA repair factor IIH helicase subunit XPD | 0 | 0 | 1 | 1 |
Casein kinase II subunit alpha' | 0 | 0 | 1 | 1 |
Ras-related protein Rab-6A | 0 | 0 | 1 | 1 |
Ephrin type-A receptor 1 | 0 | 0 | 1 | 1 |
Multifunctional protein ADE2 | 0 | 0 | 1 | 1 |
cAMP-dependent protein kinase catalytic subunit beta | 0 | 0 | 1 | 1 |
Ferrochelatase, mitochondrial | 0 | 0 | 1 | 1 |
Ribosomal protein S6 kinase beta-1 | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase JAK1 | 0 | 0 | 1 | 1 |
Probable ATP-dependent RNA helicase DDX6 | 0 | 0 | 1 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 3 | 0 | 0 | 1 | 1 |
MAP/microtubule affinity-regulating kinase 3 | 0 | 0 | 1 | 1 |
Deoxycytidine kinase | 0 | 0 | 1 | 1 |
Ephrin type-A receptor 2 | 0 | 0 | 1 | 1 |
Ephrin type-B receptor 2 | 0 | 0 | 1 | 1 |
Non-receptor tyrosine-protein kinase TYK2 | 0 | 0 | 1 | 1 |
UMP-CMP kinase | 0 | 0 | 1 | 1 |
Phosphatidylethanolamine-binding protein 1 | 0 | 0 | 1 | 1 |
Wee1-like protein kinase | 0 | 0 | 1 | 1 |
Heme oxygenase 2 | 0 | 0 | 1 | 1 |
S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 1 | 1 |
DnaJ homolog subfamily A member 1 | 0 | 0 | 1 | 1 |
RAC-alpha serine/threonine-protein kinase | 0 | 0 | 1 | 1 |
RAC-beta serine/threonine-protein kinase | 0 | 0 | 1 | 1 |
Dual specificity protein kinase TTK | 0 | 0 | 1 | 1 |
DNA replication licensing factor MCM4 | 0 | 0 | 1 | 1 |
Myosin-10 | 0 | 0 | 1 | 1 |
Dual specificity mitogen-activated protein kinase kinase 2 | 0 | 0 | 1 | 1 |
Receptor-type tyrosine-protein kinase FLT3 | 0 | 0 | 1 | 1 |
Bone morphogenetic protein receptor type-1A | 0 | 0 | 1 | 1 |
Activin receptor type-1B | 0 | 0 | 1 | 1 |
TGF-beta receptor type-1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase receptor R3 | 0 | 0 | 1 | 1 |
TGF-beta receptor type-2 | 0 | 0 | 1 | 1 |
Electron transfer flavoprotein subunit beta | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase CSK | 0 | 0 | 1 | 1 |
Glycine--tRNA ligase | 0 | 0 | 1 | 1 |
Protein kinase C iota type | 0 | 0 | 2 | 2 |
Exosome RNA helicase MTR4 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 2 | 1 | 3 |
Tyrosine-protein kinase Tec | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase ABL2 | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase FRK | 0 | 0 | 1 | 1 |
G protein-coupled receptor kinase 6 | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase SYK | 0 | 0 | 1 | 1 |
26S proteasome regulatory subunit 6B | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 8 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 9 | 0 | 0 | 1 | 1 |
Dual specificity mitogen-activated protein kinase kinase 3 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0 | 0 | 1 | 1 |
Casein kinase I isoform alpha | 0 | 0 | 1 | 1 |
Casein kinase I isoform delta | 0 | 0 | 1 | 1 |
MAP kinase-activated protein kinase 2 | 0 | 0 | 1 | 1 |
Elongation factor Tu, mitochondrial | 0 | 0 | 1 | 1 |
Choline-phosphate cytidylyltransferase A | 0 | 0 | 1 | 1 |
Cysteine--tRNA ligase, cytoplasmic | 0 | 0 | 1 | 1 |
Casein kinase I isoform epsilon | 0 | 0 | 1 | 1 |
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | 0 | 0 | 1 | 1 |
Dual specificity protein kinase CLK1 | 0 | 0 | 1 | 1 |
Dual specificity protein kinase CLK2 | 0 | 0 | 1 | 1 |
Dual specificity protein kinase CLK3 | 0 | 0 | 1 | 1 |
Glycogen synthase kinase-3 alpha | 0 | 0 | 1 | 1 |
Glycogen synthase kinase-3 beta | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 7 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 9 | 0 | 0 | 1 | 1 |
Ras-related protein Rab-27A | 0 | 0 | 1 | 1 |
Interleukin-1 receptor-associated kinase 1 | 0 | 0 | 1 | 1 |
Ribosomal protein S6 kinase alpha-3 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase Nek2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase Nek3 | 0 | 0 | 1 | 1 |
Dual specificity mitogen-activated protein kinase kinase 6 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase PLK1 | 0 | 0 | 1 | 1 |
LIM domain kinase 1 | 0 | 0 | 1 | 1 |
LIM domain kinase 2 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 10 | 0 | 0 | 1 | 1 |
Tyrosine--tRNA ligase, cytoplasmic | 0 | 0 | 1 | 1 |
Ephrin type-B receptor 3 | 0 | 0 | 1 | 1 |
Ephrin type-A receptor 5 | 0 | 0 | 1 | 1 |
Ephrin type-B receptor 4 | 0 | 0 | 1 | 1 |
Ephrin type-A receptor 4 | 0 | 0 | 1 | 1 |
Adenylate kinase 2, mitochondrial | 0 | 0 | 1 | 1 |
Ras-related protein Rab-10 | 0 | 0 | 1 | 1 |
Actin-related protein 3 | 0 | 0 | 1 | 1 |
Actin-related protein 2 | 0 | 0 | 1 | 1 |
GTP-binding nuclear protein Ran | 0 | 0 | 1 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
Casein kinase I isoform gamma-2 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 6 | 0 | 0 | 1 | 1 |
Cyclin-dependent-like kinase 5 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 16 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 17 | 0 | 0 | 1 | 1 |
ATP-dependent 6-phosphofructokinase, platelet type | 0 | 0 | 1 | 1 |
Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 0 | 1 | 1 |
DNA topoisomerase 2-beta | 0 | 0 | 1 | 1 |
Protein kinase C theta type | 0 | 0 | 2 | 2 |
Activin receptor type-1 | 0 | 0 | 1 | 1 |
Macrophage-stimulating protein receptor | 0 | 0 | 1 | 1 |
Focal adhesion kinase 1 | 0 | 0 | 1 | 1 |
Protein kinase C zeta type | 0 | 0 | 2 | 2 |
Protein kinase C delta type | 0 | 1 | 2 | 3 |
Tyrosine-protein kinase BTK | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 18 | 0 | 0 | 1 | 1 |
Activated CDC42 kinase 1 | 0 | 0 | 1 | 1 |
Epithelial discoidin domain-containing receptor 1 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase kinase 2 | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Mer | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 4 | 0 | 0 | 1 | 1 |
Dual specificity mitogen-activated protein kinase kinase 5 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 7 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase PAK 2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 3 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 1 | 0 | 0 | 1 | 1 |
Integrin-linked protein kinase | 0 | 0 | 1 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 1 | 0 | 0 | 1 | 1 |
Non-receptor tyrosine-protein kinase TNK1 | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit delta | 0 | 0 | 1 | 1 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 1 | 1 |
Activin receptor type-2B | 0 | 0 | 1 | 1 |
Bone morphogenetic protein receptor type-2 | 0 | 0 | 1 | 1 |
Protein-tyrosine kinase 6 | 0 | 0 | 1 | 1 |
cGMP-dependent protein kinase 1 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 13 | 0 | 0 | 1 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon | 0 | 0 | 1 | 1 |
Protein-tyrosine kinase 2-beta | 0 | 0 | 1 | 1 |
Maternal embryonic leucine zipper kinase | 0 | 0 | 1 | 1 |
Structural maintenance of chromosomes protein 1A | 0 | 0 | 1 | 1 |
Chromodomain-helicase-DNA-binding protein 4 | 0 | 0 | 1 | 1 |
Peroxisomal acyl-coenzyme A oxidase 1 | 0 | 0 | 1 | 1 |
Delta(24)-sterol reductase | 0 | 0 | 1 | 1 |
Ribosomal protein S6 kinase alpha-1 | 0 | 0 | 1 | 1 |
Dual specificity testis-specific protein kinase 1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase STK11 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase N1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase N2 | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent protein kinase type IV | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 11 | 0 | 0 | 1 | 1 |
Discoidin domain-containing receptor 2 | 0 | 0 | 1 | 1 |
AP2-associated protein kinase 1 | 0 | 0 | 1 | 1 |
Myosin light chain kinase 3 | 0 | 0 | 1 | 1 |
Uncharacterized aarF domain-containing protein kinase 5 | 0 | 0 | 1 | 1 |
Programmed cell death protein 4 | 0 | 0 | 1 | 1 |
Putative heat shock protein HSP 90-beta 2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase MRCK alpha | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase MRCK gamma | 0 | 0 | 1 | 1 |
Acyl-CoA dehydrogenase family member 10 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase N3 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase ULK3 | 0 | 0 | 1 | 1 |
Uncharacterized protein FLJ45252 | 0 | 0 | 1 | 1 |
Acyl-CoA dehydrogenase family member 11 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase/endoribonuclease IRE2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase MARK2 | 0 | 0 | 1 | 1 |
ATP-dependent RNA helicase DHX30 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase TAO1 | 0 | 0 | 1 | 1 |
STE20-related kinase adapter protein alpha | 0 | 0 | 1 | 1 |
Myosin-14 | 0 | 0 | 1 | 1 |
AarF domain-containing protein kinase 1 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase kinase 3 | 0 | 0 | 1 | 1 |
MAP kinase-activated protein kinase 5 | 0 | 0 | 1 | 1 |
Regulatory-associated protein of mTOR | 0 | 1 | 0 | 1 |
Misshapen-like kinase 1 | 0 | 0 | 1 | 1 |
Atypical kinase COQ8A, mitochondrial | 0 | 0 | 1 | 1 |
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 15 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase Nek9 | 0 | 0 | 1 | 1 |
ATP-dependent RNA helicase DDX1 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase kinase 1 | 0 | 0 | 1 | 1 |
Aurora kinase B | 0 | 0 | 1 | 1 |
MAP/microtubule affinity-regulating kinase 4 | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent protein kinase type 1G | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase Nek1 | 0 | 0 | 1 | 1 |
PAS domain-containing serine/threonine-protein kinase | 0 | 0 | 1 | 1 |
Calcium/calmodulin-dependent protein kinase kinase 2 | 0 | 0 | 1 | 1 |
EKC/KEOPS complex subunit TP53RK | 0 | 0 | 1 | 1 |
Dual specificity testis-specific protein kinase 2 | 0 | 0 | 1 | 1 |
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 5 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 3 | 0 | 0 | 1 | 1 |
Eukaryotic translation initiation factor 2-alpha kinase 1 | 0 | 0 | 1 | 1 |
Target of rapamycin complex subunit LST8 | 0 | 1 | 0 | 1 |
Nucleolar GTP-binding protein 1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase D2 | 0 | 0 | 1 | 1 |
RNA cytidine acetyltransferase | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase SIK2 | 0 | 0 | 1 | 1 |
STE20-like serine/threonine-protein kinase | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase TAO3 | 0 | 0 | 1 | 1 |
dCTP pyrophosphatase 1 | 0 | 0 | 1 | 1 |
Dual specificity protein kinase CLK4 | 0 | 0 | 1 | 1 |
Casein kinase I isoform gamma-1 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Phenylalanine--tRNA ligase beta subunit | 0 | 0 | 1 | 1 |
Isoleucine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
BMP-2-inducible protein kinase | 0 | 0 | 1 | 1 |
Obg-like ATPase 1 | 0 | 0 | 1 | 1 |
Midasin | 0 | 0 | 1 | 1 |
Interleukin-1 receptor-associated kinase 4 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 20 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 12 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 26 | 0 | 0 | 1 | 1 |
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase NLK | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase TBK1 | 0 | 0 | 1 | 1 |
Septin-9 | 0 | 0 | 1 | 1 |
Ribosomal protein S6 kinase alpha-6 | 0 | 0 | 1 | 1 |
TRAF2 and NCK-interacting protein kinase | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase TAO2 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase ICK | 0 | 0 | 1 | 1 |
RAC-gamma serine/threonine-protein kinase | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase SIK3 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 2 | 0 | 0 | 1 | 1 |
Thyroid hormone receptor-associated protein 3 | 0 | 0 | 1 | 1 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1B | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase kinase 5 | 0 | 0 | 1 | 1 |
Receptor-interacting serine/threonine-protein kinase 3 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase MRCK beta | 0 | 0 | 1 | 1 |
Interleukin-1 receptor-associated kinase 3 | 0 | 0 | 1 | 1 |
Serine/threonine-protein kinase 24 | 0 | 0 | 1 | 1 |
Casein kinase I isoform gamma-3 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 4 | 0 | 0 | 1 | 1 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Chain A, Ribosomal protein S6 kinase alpha-1 | 0 | 1 | 0 | 1 |
Chain X, Tyrosine-protein kinase Lyn | 0 | 1 | 0 | 1 |
Chain A, Dual specificity protein kinase TTK | 0 | 0 | 1 | 1 |
Chain A, Dual specificity protein kinase TTK | 0 | 0 | 1 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 3 |
Cystine/glutamate transporter | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor delta | 0 | 0 | 1 | 1 |
Peroxisome proliferator-activated receptor delta | 0 | 1 | 1 | 2 |
Protein kinase C gamma type | 0 | 1 | 1 | 2 |
Protein kinase C eta type | 0 | 0 | 1 | 1 |
Protein kinase C epsilon type | 0 | 1 | 1 | 2 |
Serine/threonine-protein kinase D1 | 0 | 0 | 1 | 1 |
Ras guanyl-releasing protein 3 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 4 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 4 | 0 | 0 | 0 | 1 |
Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 0 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 0 | 1 | 1 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Nrf2 | 1 | 0 | 0 | 1 |
toll-like receptor 9 | 0 | 1 | 0 | 1 |
caspase recruitment domain family, member 15 | 0 | 1 | 0 | 1 |
neurotensin receptor type 1 | 0 | 0 | 1 | 1 |
receptor-interacting serine/threonine-protein kinase 2 isoform 1 | 0 | 1 | 0 | 1 |
Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 2 | 0 | 4 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidine phosphorylase | 0 | 1 | 0 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
Proliferating cell nuclear antigen | 0 | 2 | 0 | 2 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 2 | 2 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, Repressor | 0 | 0 | 1 | 1 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Endoplasmic reticulum chaperone BiP | 0 | 1 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 2 | 0 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | 0 | 2 | 0 | 2 |
Enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Enoyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
Enoyl-ACP reductase II | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
guanine nucleotide-binding protein subunit alpha-15 | 0 | 1 | 1 | 2 |
D(3) dopamine receptor isoform e | 1 | 0 | 0 | 1 |
trace amine-associated receptor 1 | 0 | 1 | 1 | 2 |
Phenylethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
Dopamine beta-hydroxylase | 0 | 0 | 0 | 1 |
Beta-secretase 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Glycoprotein | 0 | 1 | 0 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Protease | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |